CHI-MED

HUTCHISON CHINA MEDITECH
MEDIA CENTRE

Press coverage

31 March 2015 $300 - $400m potential China sales (The Times, Ireland)  
31 March 2015 Chi-Med unit achieves primary endpoint in POC trial (Share Magazine, UK)  
30 March 2015 Chi-Med's fruquintinib meets in mCRC Phase II ( BioCentury, UK)  
02 March 2015 Chi-Med: a prescription for success (The Guardian, UK)  
01 March 2015 Chi-Med nears launch of landmark drug (Financial Times, UK)  
30 January 2015 And finally...signed an interesting deal with AstraZeneca to distribute its Seroquel antipsychotic drug in China (The Times, Ireland)  
27 January 2015 Mark Slater: Traditional UK banks are a scary investment, but I do own HSBC (What Investment, UK)  
17 December 2014 Hutchison-discovered fruquintinib moves into phase III CRC trial (BioWorld Asia)  
07 October 2014 Chi-Med to give Drug R&D Briefing (Shares, UK)  
26 August 2014 Chinese pharma starts to narrow the gap (Financial Times, UK)  
10 August 2014 Our Chinese drugs tip looks healthy after doubling in three years (The mail on Sunday, UK)  
30 May 2014 Hutchison Medipharma hopes to break through with cancer drug Volitinib (Bioworld Today, UK)  
15 May 2014 Chi-Med can be a drugs winner (Evening Standard, UK)  
01 March 2014 The week's best buys - Hutchison China MediTech (The week, UK)  
01 March 2014 Why should I invest with you? (The Daily Telegraph, UK)  
21 February 2014 Hutchison China MediTech delivers (Investors Chronicle, UK)  
19 February 2014 Chi-Med doubles revenue to $46m (City AM, UK)  
19 February 2014 Chi-Med mulls independent China development of new drugs (Scrip, UK)  
19 February 2014 Need to know - Health (The Times, UK)  
18 February 2014 Chi-Med profits jump (Interactive Investor, UK)  
18 February 2014 Hutchison China MediTech after a 65% rise in operating profits to $9.6m (The Guardian, UK)  
01 February 2014 Throw the kitchen sink at RBS and stop this constant political meddling (The Daily Telegraph, United Kingdom)  
30 January 2014 Shares (United Kingdom)  
03 January 2014 Chi-Med's Sinopharm Deal Opens Doors To China Market For Partners, CEO Says (PharmAsia, China)  
03 January 2014 A victim of my own success (The Times, UK)  
19 December 2013 Hutchison China Meditech Ltd. (Chi-Med), of Hong Kong, and Sinopharm Group Co. Ltd., of Beijing, said they established a joint venture (Bioworld, UK)  
18 December 2013 Hutchison China Meditech, Sinopharm Ink Distribution Joint Venture (Dowjones, UK)  
18 December 2013 Chi-Med in JV with Sinopharm (Stock Market Wire, UK)  
28 November 2013 Profit with Slater's growth picks (Shares, UK)  
24 November 2013 Anthony Bolton: my best ever trades – The Fidelity star made fortunes for his clients. He shares some of his smartest moves with Richard Evans in Shenzhen (The Sunday Telegraph, UK)  
22 November 2013 GAME CHANGERS, Matthew Allan and the IC companies team find the Aim companies with ten-bagger innovations (Investors Chronicle, UK)  
12 November 2013 Hutchison MediPharma CEO Christian Hogg On World-Class Innovation in China: An Interview With PharmAsia News (Pharm Asia News, China)  
14 October 2013 Hutchison China MediTech Limited, LON:HCM 615p / £320.12m (Hybridan Small Cap Wrap, UK)  
14 October 2013 Hutchison MediPharma And Eli Lilly Collaborate On Cancer Therapy (Asian Scientist, UK)  
13 October 2013 China Biotech In Review: Hutchison MediPharma Partners Cancer Drug With Lilly (Seeking Alpha, UK)  
12 October 2013 Hutchison MediPharma enters cancer therapy collaboration with Eli Lilly in China (PharmaBiz, UK)  
10 October 2013 A new deal for Hutchison MediPharma (MedNous, UK)  
10 October 2013 It's case of glass half-full (The Times, UK)  
10 October 2013 Chi-Med strikes a double deal (Daily Express, UK)  
10 October 2013 Hutchison MediPharma In Pact with Lilly (WSJ)  
10 October 2013 Need to know - Health (The Times, UK)  
10 October 2013 Hutchison China Meditech (HCM) has signed a licensing and co-development deal with Eli Lilly (Investors Chronicle, UK)  
09 October 2013 Chi-Med unit in collaboration with Lilly (Stock Market Wire, UK)  
09 October 2013 Lilly hooks Hutchison for China cancer deal (Scrip, UK)  
09 October 2013 Lilly gets Chinese commercialization rights to Chi-Med compound (BioCentury Extra, UK)  
09 October 2013 Lilly enters cancer collaboration in China (PMLive)  
09 October 2013 Active Biotech and Hutchison China MediTech Get Rewarded (Genetic Engineering News)  
09 October 2013 Housebuilders in demand after City backs 'Help to Buy' (Evening Standard, UK)  
09 October 2013 Hutchison China Meditech In Eli Lilly China Deal For Cancer Treatment (Alliance News)  
09 October 2013 Hutchison China Meditech Limited Payment From Janssen Pharmaceuticals (ADVFN)  
07 October 2013 Hutchison China MediTech well placed to tap opportunities in China, say analysts (Pharma Letter)  
28 September 2013 A year to remember, but don't expect the good times to last
(The Times, UK)
 
31 July 2013 Engineer on a high after Volvo deal (The Times, UK)  
31 July 2013 Need to know (The Times, UK)  
31 July 2013 Small Companies Roundup (Daily Express, UK)  
31 July 2013 FTSE waits for interest rate decisions (The Scotsman, UK)  
30 July 2013 Property play at Hutchison China Meditech (Investors Chronicle, UK)  
30 July 2013 Chi-Med profits up (Stock Market Wire, UK)  
30 July 2013 DJ Telecity Posts 1H Profit Rise; Hutchison China Sees Growth in 2H (Dow Jones, UK)  
30 July 2013 STOCKS NEWS EUROPE-UK small caps edge higher (Reuters, UK)  
08 July 2013 Aim shares in lsas: Star managers pick their favourites (ACQ Magazine, UK)  
07 July 2013 Take Aim at total tax freedom (The Sunday Telegraph, United
Kingdom)
 
05 July 2013 Chinese medicine plays by Western rules to gain acceptance (China Economy Review, China)  
29 June 2013 As stock market predictions go, these are almost the perfect ten (The Times, UK)  
27 June 2013 Hutchison China MediTech, LON:HCM 498.5p/£259.47m (Hybridan,
UK)
 
03 June 2013 Slater keeps his cool as rally leaves him behind (Investment Adviser, UK)  
03 June 2013 Diary of a Dumb Investor: I'm investing in the North Sea (CityWire, UK)  
05 May 2013 China Biotech In Review: Chindex Buys Israeli Laser Company For $240 Million (Seeking Alpha, UK)  
29 April 2013 Hutchison to develop herbal drug with Nestle (South China Morning Post, Hong Kong)  
29 April 2013 和黃子企新藥臨牀試驗 (Sing Tao Daily, Hong Kong)  
06 April 2013 Thomas Cook leads the way as ten outpace a stumbling Footsie (The Times, UK)  
05 April 2013 Salve The World (China Daily European Weekly, UK)  
05 April 2013 Hutchison China's perfect timing (Investors Chronicle, UK)  
17 March 2013 Improved AIM can fire up your portfolio (The Sunday Times)  
14 February 2013 Feature consumer healthcare (Marketing Week)  
13 February 2013 Reckitt gets taste for Chinese remedy (FT.com)  
28 January 2013 Diary of a Dumb Investor: going for broke on Spanish gold (Citywire Money, UK)  
25 January 2013 Biotech is back (Investors Chronicle, UK)  
24 January 2013 Get a good dose of Hutchison (Shares, UK)  
13 January 2013 Nestle and Hutchison Whampoa - Are botanical drugs a new model for pharma (MedNous, UK)  
11 January 2013 Hutchison China safely Nestled (Investors Chronicle, UK)  
01 January 2013 Nestle Health Science gains access to Chi-Med Chinese medicine library (Manufacturing Chemist, UK)  
01 January 2013 Updates (Small Company Sharewatch)  
01 January 2013 Ten Shares to Follow in a Year that Begins with a Cliffhanger (The Times, UK)  
01 December 2012 Nestle eyes potential of Chinese traditional medicines (Pharmafocus, UK)  
01 December 2012 New-trition (European Biotechnology News, UK)  
29 November 2012 Chi-Med and Nestlé Health Science establish Joint Venture Press Cuttings Book  
28 November 2012 Nestle and Chi-Med form Chinese medicine alliance (South China Morning Post, Hong Kong)  
28 November 2012 和黃中醫夥雀巢組合資 (Sing Tao Daily, Hong Kong)  
05 November 2012 Hutchison China MediTech - QuickView (Edison, UK)   
01 November 2012 DJ Hutchison China Meditech Initiated Phase I trial of Theliatinib (Dow Jones, UK)   
01 October 2012 Diary of a Dumb Investor: the stock that just keeps on giving (Citywire Money, UK)   
16 September 2012 Stadium electronics is 'firmly on track' (Scotland on Sunday, Scotland)   
13 September 2012 Hutchison China Meditech director tops up stake (Money Week, UK)   
13 September 2012 Hutchison China Meditech director tops up stake (IFA Magazine, UK)   
06 August 2012 Anthony Bolton and I, kindred spirits (City Wire, UK)   
03 August 2012 SHARES I LOVE (Investors Chronicle, UK)   
03 August 2012 Hutchison shrugs off China worries (Investors Chronicle, UK)   
02 August 2012 BEST of the BROKERS (City AM, UK)   
01 August 2012 BP figures 'take wind' out of Footsie (The Scotsman, UK)   
31 July 2012 Chi-Med operating profits up 97% (Stock Market Wire, UK)   
31 July 2012 Hutchison China Meditech Limited 1H Pretax Profit Up, Prospects Strong (Dow Jones, UK)   
31 July 2012 China market booming for Chi-Med (Share Cast, UK)   
31 July 2012 China market booming for Chi-Med (Money Week, UK)   
26 June 2012 Able hands steer canny course (Money Observer, UK)   
13 June 2012 The 14 stocks Bolton is backing to turn around performance (Investment Week, UK)   
12 June 2012 Bolton's blues continue as China fund drops 20 pct (Reuter, UK)   
14 May 2012 Top performing funds acclaim importance of firms that export (New Model Adviser, UK)   
21 April 2012 Will this be the year of the bull or year of the bear for China? (The Telegraph, UK)   
13 April 2012 Hutchison MediPharma expects FDA green light this year for herbal IBD drug Phase III start (BioPharm Insight, UK)   
01 April 2012 Hutchison China Meditech - 2012 starts with a bang (Small Company Sharewatch, UK)   
25 March 2012 Take Aim at the taxman (The Sunday Telegraph, UK)   
23 March 2012 Traditional Chinese Medicine Gets Down to Drug Discovery Roots (BioWorld, UK)   
23 March 2012 Hutchison China delivers again (Investors Chronicle, UK)   
21 March 2012 Chi-Med in the black as sales surge (The Scotsman, UK)  
21 March 2012 Press Release (Proactive Investors.co.uk, UK)  
20 March 2012 Chi-Med posts maiden net profit as revenues rise (The Daily Telegraph, UK)   
20 March 2012 Press Release (Money AM, UK)   
20 March 2012 Hutchison China Meditech Swings Back to FY Profit of $4.8M (Dow Jones, UK)   
20 March 2012 Chi-Med posts maiden net profit as revenues rise 24% (StockMarketWire.com, UK)   
17 March 2012 Results due next week (Financial Times, UK)   
16 March 2012 Press release (London Stock Exchange, UK)   
16 March 2012 Press release (Motley Fool UK, UK)   
13 March 2012 UK economy could not recover for more than five years (The Daily Telegraph, UK)   
29 February 2012 Stomach, Lung, Liver Cancers Key to Pacific Rim Innovation (BioWorld International, USA)   
22 February 2012 DJ Hutchison China's Voltinib Phase 1 Trial Initiated (Dow Jones, UK)   
22 February 2012 Wednesday broker round-up (IFA Magazine, UK)   
22 February 2012 Europe Research Round-up (Reuters, UK)   
23 January 2012 Met-ing the neighbors (BioCentury Week, UK)   
24 December 2011 ChiMed announces global deal with AstraZeneca (Financial Times, UK)   
22 December 2011 AstraZeneca Enters Into Licensing Agreement With Hutchison MediPharma For Volitinib (GlobalData Financial Deals Tracker, UK)   
22 December 2011 Drugs giant in deals to boost pipeline (The Herald, UK)   
22 December 2011 AstraZeneca bets on Asia research (City AM, UK)   
22 December 2011 Press Release (Telegraph.co.uk, UK)   
22 December 2011 Astra back on top with new drug deals (The Daily Mail, UK)   
22 December 2011 Astra turns to Asia (The Daily Express, UK)   
22 December 2011 Festive retail woes 'may have been overcooked' (The Independent, UK)   
22 December 2011 AstraZeneca signs two deals to boost pipeline after recent disappointments (Guardian.co.uk, UK)   
22 December 2011 Market forces Astra falters as new deals fail to impress City (The Guardian, UK)   
22 December 2011 Chi-Med in £89m deal with Astra (The Scotsman, UK)   
22 December 2011 AstraZeneca looks east for supply of new blockbusters (The Times, UK)   
21 December 2011 AstraZeneca PLC Strikes New Deals Worth $140 Million With Hutchison China MediTech (Chi-Med) and Astellas Pharma US After R&D Setbacks (BioSpace, UK)   
21 December 2011 Hutchison MediPharma nets AstraZeneca for anti-cancer drugs (China Knowledge Press, UK)   
21 December 2011 AstraZeneca signs two deals (Investor's Business Daily, UK)   
21 December 2011 Hutchison China Meditech soars after AstraZeneca link-up (Interactive Investor, UK)   
21 December 2011 AZ commits $140M to cancer pact as it inks back-to-back deals (Fierce Biotech, UK)   
21 December 2011 Hutchinson, AstraZeneca Ink Deal for c-Met Inhibitor with $20M Up Front (GEN, UK)   
21 December 2011 AZN - AstraZeneca (Sharecast, UK)   
21 December 2011 AstraZeneca and HMP to co-develop cancer therapy (Stock Market Wire, UK)   
21 December 2011 Hutchison China Meditech soars after AstraZeneca link-up (In-Pharm, UK)   
21 December 2011 Press Release (Proactive Investors, UK)   
21 December 2011 MarketWatch/Wall Street Journal (MarketWatch/Wall Street Journal, UK)   
21 December 2011 AstraZeneca places two new bets after R&D setbacks (Reuters, UK)   
21 December 2011 STOCKS NEWS EUROPE-Hutchison Chi-Med jumps on Astra deal (Reuters, UK)   
21 December 2011 Hutchison China Meditech, AstraZeneca Agree Cancer Therapy Pact (Dow Jones, UK)   
21 December 2011 AstraZeneca Signs Two Asian Drug Development Deals (Dow Jones, UK)   
21 December 2011 AstraZeneca in deals with Chi-Med, Astellas (BioCentury Extra, UK)   
21 December 2011 AstraZeneca tries to plug development gap with two Asian deals (Scrip, UK)   
21 December 2011 Hutchison China MediTech, AstraZeneca Agree Cancer Therapy Pact (Dow Jones, UK)   
21 December 2011 AstraZeneca places two new bets after R&D setbacks (Reuters, UK)   
21 December 2011 AstraZeneca to Develop Cancer Treatment with Hutchison China (Bloomberg, UK)   
12 December 2011 Chi-Med unit granted loan of up to HK$210m
(The Daily Telegraph, UK) 
 
12 December 2011 Hutchison China Meditech Unit Agrees $27m Loan Facility
(Dow Jones, UK) 
 
03 October 2011 Press Release
(Mail Online, UK) 
 
25 August 2011 Why there is still juice in the tank for quality growth companies
(Professional Adviser, UK)
 
02 August 2011 New Drug Made From Herb, Naturally
(Wall Street Journal, UK)
 
02 August 2011 Hutchison China Meditech
(Proactive Investors.co.uk, UK) 
 
02 August 2011 Hutchison China at a discount
(Investors Chronicle, UK) 
 
01 August 2011 Chi-Med outlook positive as operating profits rise 28% (stockmarketwire.com, UK)  
01 August 2011 Hutchison China Meditech 1H Pretax Profit Up 28% To $2.7m
(Dow Jones Newswires, UK) 
 
23 July 2011 Chi-Med expands its horizons with joint venture in China
(The Scotsman, UK)
 
22 July 2011 Chi-med expands OTC drug distribution
(Money AM, UK) 
 
23 June 2011 Q & A
(Citywire Weath Manager, UK) 
 
23 June 2011 Chinese dragon unlikely to slay global recovery
(Shares, UK) 
 
16 June 2011 Slater seeks out growth at a reasonable price
(MShares, UK) 
 
01 June 2011 Hutchison unit enters China's premium infant milk market
(China Daily, China)
 
01 June 2011 Deep value approach reaps rich harvest
(Money Observer, UK) 
 
26 May 2011 HAIN CEO Speaks to Jim Cramer
(CNBC, United States) 
 
23 May 2011 Chi-Med set for profit
(Mail Online, UK)
 
15 March 2011 A healthy prognosis for Chi-Med
(Proactive Investors.co.uk, UK) 
 
14 March 2011 Launching Hutchison Port
(Barron's, UK) 
 
11 March 2011 Chi-Med losses down on strong Chinese healthcare sales
(Scrip, UK) 
 
09 March 2011 Chi-Med operating losses down 52%
(Money AM, UK) 
 
09 March 2011 Hutchison Chi-Med Optimistic About 2011, Drug Trial Eyed
(Dow Jones, UK) 
 
09 March 2011 Hutchison China's HMPL-004 Trials Eyed - Panmure
(Dow Jones, UK) 
 
09 March 2011 Hutchison China Meditech narrowed full-year losses
(ShareCast, UK) 
 
03 March 2011 Hutchison China MediTech is a good way to get Chinese exposure
(Shares, UK) 
 
01 March 2011 Small-cap stars
(Business XL, UK) 
 
22 February 2011 Executive board promotion at Chi-Med
(Scrip, UK) 
 
15 February 2011 European Organic Food Industry: Spike in Investment Activity Envisaged
(Organic Monitor, UK)
 
03 February 2011 8 Chinese crackers
(Shares, UK)  
 
27 January 2011 A night to celebrate success
(City AM, UK)  
 
24 January 2011 The art of picking and choosing the right stocks
(Investment Adviser, UK)  
 
20 January 2011 Penny's Growth Picks For A Prosperous 2011
(Citywire Wealth Manager, UK)  
 
January 2011 Market Comment and Updates
(The Small company Share Watch, UK)  
 
01 January 2011 An evening with Jim Slater
(Investing for Growth, UK)  
 
01 January 2011 Top share tips for 2011
(Daily Express, UK)  
 
31 December 2010 Trusting the tips would have put you ahead of the market
(The Times, UK)  
 
27 December 2010 Mitsui, other traders putting chips on Chinese start-ups
(The Nikkei Weekly, UK)  
 
26 December 2010 Shares will fly again in 2011
(The Sunday Times, UK)  
 
24 December 2010 MoneyWeek's top ten tipsters of 2010
(Money Week, UK)  
 
23 December 2010 Upbeat outlook
(Shares, UK)  
 
22 December 2010 Hutchison MediPharma Gains Funding From SB China
(Dow Jones VentureWire Lifescience, UK)  
 
10 December 2010 Hutchison China MediTech Increases Indirect Ownership of OTC JV
(Dow Jones, UK)  
 
22 November 2010 Mark Slater puts his faith in the Zulu Principle
(Financial News, UK)  
 
09 November 2010 Investment gives Mitsui 12% of Hutchison MediPharma
(Scrip, UK)  
 
09 November 2010 Gains for oil and gas groups
(Financial Times, UK)  
 
28 October 2010 World Wide Wonders
(Shares, UK)  
 
21 October 2010 Piper Jaffray exit
(Financial Times, UK)  
 
18 October 2010 In for a penny
(Investment Week, UK)  
 
16 October 2010 Up 44 per cent, going strong: how's that for an investment ?
(The Times, UK)  
 
02 September 2010 Chi-Med's march to profitability
(Shares, UK)  
 
August 2010 No Hain, No Gain ?  
26 August 2010 Aim's strengths may obviate need for doom and gloom
(Financial Times, UK)  
 
21 August 2010 East offers prescription for west's growth plans
(Financial Times, UK) 
 
30 July 2010 Hutchison China sales surge 29%
(The Scotsman (Business), UK) 
 
29 July 2010 Chi-Med operating profit up 314%
(Business Financial Newswire, UK)
 
29 July 2010 Chi-Med moves closer to spinning off R&D division
(Scrip, UK) 
 
29 July 2010 Hutchison Chi-Med Loss Narrows; Bowel Drug Trial Starts Soon
(Dow Jones, UK) 
 
29 July 2010 Hutchison Chi-Med Narrows Loss on Sales Boost
(Dow Jones, UK) 
 
29 July 2010 Hutchison Chi-Med looking to spin-off R&D unit
(Reuters, UK) 
 
July 2010 Market Comment
(The Small Company Sharewatch, UK)
 
26 June 2010 Impact of BP's troubles helps Tempus Ten to beat the market
(The Times, UK)
 
26 June 2010 City Tips
(Yorkshire Post, UK)
 
18 June 2010 Three stocks with plenty of growth potential
(Money Week, UK)
 
01 June 2010 Updates & Ideas
(Small Company Sharewatch, UK)
 
27 May 2010 Star Fund Managers 10 choicest picks
(Shares, UK)
 
April 2010 CNBC Asia Squawk Box Asia  
04 March 2010 Hutchison Chi-Med Seeks R&D Investor As Loss Narrows
(Dow Jones, UK)
 
04 March 2010 Chi-Med plans largest Chinese biotech listing on Nasdaq
(Scrip, UK)
 
11 February 2010 Hutchison China MediTech (HCM:AIM) 194p
(Shares, UK)
 
13 January 2010 Long-term investments more attractive than gold
(Daily Express, UK)
 
01 January 2010 Chi-Med Shares rose fivefold in 2009
(Times, UK)
 
23 Decemeber 2009 Chinese medicine firm employs Cambridge to research remedies
(The Guardian, UK)
 
23 Decemeber 2009 Chi-Med's eastern promise
(The Guardian, UK)
 
06 November 2009 Chi-Med profits from Chinese pharma sentiment
(EP Vantage, UK)
 
06 November 2009 Hutchison China MediTech climbed 16p to 186.5p
(The guardian, UK)
 
06 November 2009 Hutchison China's HMPL-004 meets Phase IIb endpoint
(BioCentury, UK)
 
06 November 2009 Overseas Regulatory Announcement from Hutchison Whampoa
(Dow Jones, UK)
 
06 November 2009 Hutchison MediPharma announces completion of Phase IIb trial for HMPL-004 in ulcerative colitis
(M2 Pharma, UK)
 
06 November 2009 Hutchison Chi-Med up on drug data
(Reuters, UK)
 
05 November 2009 Hutchison China successful drug trial
(IBTimes, UK)
 
28 August 2009 Health ministry's decision is just what doctor ordered
(The Scotsman, UK)
 
28 August 2009 Hutchison China MediTech rose 4½p to 120p
(The Times, UK)
 
09 August 2009 Can China Cure the west's ills ?
(The Observer, UK)
 
06 August 2009 Chi-Med still a buy
(Shares, UK)
 
31 July 2009 Maiden profit from Hutchison China MediTech
(Investors Chronicle, UK)
 
31 July 2009 Chi-Med unveils maiden profit
(The Scotsman, UK)
 
30 July 2009 Chi-Med posts first ever half-year pre-tax profits
(Scrip, UK)
 
30 July 2009 Hutchison China MediTech climbs to profit from loss on sales +23%
(Dow Jones, UK)
 
30 July 2009 Healthy results show Chi Med's going cheap
(London Evening Standard, UK)
 
14 July 2009 Chi-Med happy with drug tests
(The Scotsman, UK)
 
14 July 2009 Huchison China MediTech rose 12.5 per cent to 76½p
(Financial Times, UK)
 
14 July 2009 Hutchison China MediTech was 8.5p higher at 76.5p
(The Guardian, UK)
 
14 July 2009 Huchison China MediTech rose 8½p to 66p
(The Times, UK)
 
13 July 2009 Hutchison MediPharma's drug for treatment of CD shows positive results in Phase II Trial
(M2 Pharma, UK)
 
13 July 2009 Hutchison China MediTech : Encouraging Crohn's Trial
(Dow Jones, United States)
 
26 June 2009 Hutchison MediPharma's Solid Tumor Drug First Oncology Project To Enter SFDA Fast-track Approval  
28 May 2009 China's show of strength
(Shares (Main), UK)
 
07 May 2009 Research upside at Hutchison
(Shares (Main), UK)
 
13 April 2009 Lilly focuses on R&D as rivals eye M&As
(China Daily, China)
 
17 March 2009 Chinese demand boosts Hutchison China
(Investors Chronicle, UK)
 
17 March 2009 'Watershed' year depends on US drugs trial
(The Scotsman, UK)
 
16 March 2009 Hutchison China MediTech up after results
(Reuters UK, UK)
 
09 January 2009 Clinical setback in lung cancer for key Chi-Med project
(Scrip, UK)
 
30 December 2008 Broker Snaps : Panmure Gordon has reiterated its "buy" rating on Hutchison China Meditech
(The Scotsman, UK)
 
21 November 2008 Hutchison China, Eli Lilly expand drug deal
(Reuters, UK)
 
07 August 2008 Chi-Med in rude health as sales soar by 37%
(The Scotsman, UK)
 
07 August 2008 Chi-Med holds talks with takeover targets
(Toronto Star, Canada)
 
07 August 2008 Herbal attraction
(Guardian, UK)
 
06 August 2008 Hutchison Chi-Med Rises on Sales Surge
(Dow Jones, United States)
 
06 August 2008 Hutchison China MediTech Mulls IPO for R&D Unit
(Dow Jones, United States)
 
06 August 2008 Hutchison China MediTech 1H Pretax Losses $4M Vs $2.6M
(Dow Jones, United States)
 
06 August 2008 Hutchison China Meditech says confident about future despite H1pretax loss
(Forbes, United States)
 
06 August 2008 Hutchison China Meditech moved up 8-1/2 pence to 123-1/2 pence
(Interactive Investor, UK)
 
10 June 2008 Chi-Med non-exec director Howell buys 25,000 shares at 122p/shr
(AFX News, UK)
 
23 May 2008 Hutchison China Meditech increases stake in Hutchison Healthcare
(Forbes, United States)
 
23 May 2008 China Medi-Tech Ups Stake In Hutchison Healthcare To 85%
(Dow Jones, United States)
 
23 May 2008 Hutchison China Meditech increases stake in Hutchison Healthcare
(AFX News, UK)
 
19 May 2008 DJ Hutchison China Meditech Launches Sen In France
(Dow Jones, United States)
 
19 May 2008 Hutchison China signs distribution agreement with Marionnaud
(AFX News, UK)
 
19 May 2008 Chi-Med has struck an exclusive distribution agreement with Marionnaud Parfumeries
(The Times, UK)
 
19 May 2008 Expansion of Consumer Products division Sen launches in 125 Marionnaud beauty stores
(Digital Look, UK)
 
08 May 2008 Medicine looks back to its roots, barks, moulds and leaves
(Financial Times, UK)
 
07 May 2008 Bringing the best of Chinese healthcare to the market in the West
(Scotsman, UK)
 
19 March 2008 Hutchison China Medical FY Pretax Loss $10M Vs $5.8M
(Dow Jones, United States)
 
19 March 2008 Hutchison China Meditech FY pretax loss widens; confident for 2008
(AFX News, UK)
 
29 February 2008 Hutchison China Meditech Starts HMPL-004 Ph IIB Trial
(Dow Jones, United States)
 
29 February 2008 Hutchison China starts patient enrolment for anti-inflammatory drug phase IIB
(AFX News, UK)
 
22 November 2007 Hutchison China Meditech unit to start phase IIb trial of colitis drug candidate
(Forbes, United States)
 
16 November 2007 Climbing the life-sciences curve
(The Deal.com, Corporate Dealmaker)
 
24 August 2007 Hutchison shores up defences of British empire
(The Daily Telegraph, UK)
 
23 August 2007 Eli Lilly, Chi-Med Team Up on Cancer Drugs
(The Wall Street Journal, United States)
 
22 August 2007 Lilly signs drug discovery deal with Chi-Med for oncological candidates
(Scrip World Pharmaceutical News, UK)
 
21 August 2007 Eli Lilly, Shanghai firm to develop cancer drugs
(The Wall Street Journal, Europe)
 
21 August 2007 Market forces
(The Guardian, UK)
 
21 August 2007 Hutchison China Meditech
(Financial Times, UK)
 
21 August 2007 Lilly in oncology and anti-inflammatory pact with China firm
(Pharma Times, UK)
 
20 August 2007 2nd UPDATE: Hutchison Chi-Med Shrs Rise On Tie Up With Lilly
(Dow Jones, United States)
 
20 August 2007 Hutchison China, Lilly to Develop Cancer Treatments (Update3)
(Bloomberg, United States)
 
20 August 2007 Chi-Med in R&D deal with Eli Lilly
(The Independent, UK)
 
20 August 2007 Eli Lilly turns to Chi-Med
(Daily Telegraph, UK)
 
20 August 2007 Lilly in £30m Chinese medicine deal
(Daily Express, UK)
 
20 August 2007 Chinese drug deal
(The Times, UK)
 
20 August 2007 Health
(The Times, UK)
 
20 August 2007 Monday Papers
(Reuters UK, UK)
 
30 July 2007 Chi-Med develops treatment for IBD
(Chemisty & Industry, UK)
 
07 July 2007 Making the right moves in China
(The Telegraph, UK)
 
03 July 2007 Crohn's drug gives MediTech big break
(The Independent, UK)
 
03 July 2007 Questor says Speculative Buy
(The Daily Telegraph, UK)
 
03 July 2007 Chi-Med's herbal-derived colitis therapy shows promise
(Scrip World Pharmaceutical News, UK)
 
03 July 2007 Strong herb
(The Guardian, UK)
 
02 July 2007 Hutchison China Says Bowel Drug Test Is `Positive' (Update2)
(Bloomberg, United States)
 
02 July 2007 Outlook healthy for Chi-Med
(Evening Standard, UK)
 
02 July 2007 Hutchison China MediTech Chi-Med phase II study for HMPL-004
(Dow Jones, United States)
 
02 July 2007 Hutchison China Meditech says positive Phase II data for ulcerative colitis drug
(Forbes, United States)
 
18 June 2007 Hutchison China Meditech acquires Shanghai facility for 3.3 mln usd
(Forbes, United States)
 
04 June 2007 Ancient Secrets
(Forbes, United States)
 
23 May 2007 Hutchison China Meditech says HMPL-004 POC Phase II trial on time, below cost
(Forbes, United States)
 
22 May 2007 Hutchison China CEO Hogg lifts stake in co to 1.1 pct
(Forbes.com, United States)
 
21 May 2007 Ancient Secrets
(Forbes Asia, Singapore)
 
02 May 2007 Science goes to China
(The Scientist, UK)
 
30 March 2007 Aim: Chinese Botanical Medicines
(Investors Chronicle, UK)
 
30 March 2007 Quotes of the Week
(Investors Chronicle, UK)
 
22 March 2007 Health
(The Times, UK)
 
21 March 2007 DJ Hutchison China MediTech FY Pretax Losses $8.6M Vs $6.2M
(Dow Jones, UK)
 
21 March 2007 Edited Press Release
(Dow Jones, UK)
 
15 February 2007 Is this a magic potion from Li Ka-shing?
(Evening Standard, UK)
 
29 January 2007 Chi-Med boost as China state secret
(The Daily Telegraph, UK)
 
14 January 2007 Chinese falter on Aim
(The Sunday Telegraph, UK)
 
03 January 2007 Business Daily
(BBC Word Service Radio, UK)
 
19 December 2006 Heady future for China's ancient potions
(The Daily Telegraph, UK)
 
19 December 2006 Hutchison's TCM arm needs share price tonic
(The Daily Telegraph, UK)
 
21 November 2006 The Investment Column: Hutchison China MediTech
(The Independent, UK)
 
20 November 2006 Merck looks for ancient Chinese cancer cure
(The Independent, UK)
 
20 November 2006 Chi-Med signs deal with Merck for research into cancer treatments
(Financial Times, UK)
 
20 November 2006 Merck embraces Chinese remedy
(The Daily Telegraph, UK)
 
20 November 2006 Merck takes dose of alternative medicine
(The Times, UK)
 
09 November 2006 Hutchison China MediTech Expects Profit From 2008 (Correct)
(Bloomberg, New York)
 
06 November 2006 Hutchison China Medi Development Agreement
(Dow Jones, UK)
 
06 November 2006 Hutchison Chi-Med signs Proctor & Gamble beauty deal
(Sharecast, UK)
 
13 October 2006 China Town
(Investors Chronicle, UK)
 
18 August 2006 Aim: traditional Chinese medicine
(Investors Chronicle, UK)
 
17 August 2006 First Timers: Tracking the maiden results
(Shares, UK)
 
10 August 2006 Chi-Med reports booming sales
(Guardian, UK)
 
10 August 2006 Chi-Med seeks links for growth in China
(The Daily Telegraph, UK)
 
10 August 2006 Chi-Med looks to joint ventures
(Financial Times, UK)
 
10 August 2006 Bird flu fight a tonic for Chi-Med
(Daily Express, UK)
 
09 August 2006 Chi-Med H1 sales up 86 pct, sees progress in 2006
(Reuters, UK)

 
09 August 2006 Hutchison Chi-Med doubles sales
(Sharecast, UK)
 
07 August 2006 Eastern promise means boomtime for Aim
(The Guardian, UK)
 
18 July 2006 Chi-Med suffers regulatory setback
(Financial Times, UK)
 
18 July 2006 Small-caps: Rosy outlook for Russian project lifts aricom
(Financial Times, UK)
 
18 July 2006 Rule changes hit Chi-Med
(Financial Times, UK)
 
18 July 2006 Big buyer is big loser as bumpy ride goes on
(Guardian, UK)
 
18 July 2006 Nervous Mood As Sums Squabble Starts Over 3i
(Evening Standard, UK)
 
17 July 2006 Hutchison China Meditech Sales Rise on Bird Flu Concerns
(Bloomberg, New York)
 
17 July 2006 Hutchison China Share Slump on Authority's Ruling (Update 2)
(Bloomberg, New York)
 
04 July 2006 DJ Hutchison China: Preparing for US Phase I/II Trials
(Dow Jones, UK)
 
04 July 2006 Hutchison Chi-Med given go-ahead to broaden scope of cancer drug trial
(AFX News, UK)
 
02 June 2006 Legal firm aids Chinese deal
(Sheffield Star, UK)
 
20 May 2006 Many debutants opt to bite the bullet
(Financial Times, UK)
 
19 May 2006 Market report: Nerves are steadied as calm returns to Footsie
(Evening Standard, UK)
 
19 May 2006 DLA Piper advises Hutchison China Meditech Limited on AIM listing
(DLA Piper, UK)
 
19 May 2006 China's Chi-Med to start trading on AIM
(Reuters, UK)
 
12 May 2006 Chi-Med to float this month
(Scrip World Pharmaceutical News, UK)
 
10 May 2006 IPO values Hutchison medical unit at 141 mil stg
(Reuters, UK)
 
10 May 2006 DJ Hutchison China Meditech IPO shares priced at 275p
(Dow Jones Newswires, UK)
 
10 May 2006 Hutchison China Meditech's IPO priced at 275p
(AFX UK Focus, UK)
 
28 April 2006 Hong Kong Hutchison shareholders to get preferential deal in unit's London IPO
(AFX News Limited, UK)
 
27 April 2006 China could be big medicine
(The Evening Standard, UK)
 
14 April 2006 Chi-Med to raise R&D funds through London float
(Scrip World Pharmaceutical News, UK)
 
12 April 2006 Chi-Med to raise R&D funds through London float
(Scrip Daily News, UK)
 
11 April 2006 Hutchison China Meditech to list on AIM
(BioCentury, UK)
 
10 April 2006 Chinese drug maker infused with the spirit of London
(The Times, UK)
 
10 April 2006 First UK listing for a Chinese medicine firm
(The Scotsman, UK)
 
10 April 2006 Chinese herbal drug firm floats in London
(The Independent, UK)
 
10 April 2006 A Sen shop in London: Sen is planning to open stores in South Korea
(The Independent, UK)
 
10 April 2006 First Chinese medicine firm floats in London to fund research
(The Guardian, UK)
 
10 April 2006 Chinese medicine looks to AIM listing
(The Daily Telegraph, UK)
 
10 April 2006 Chi-Med to tap into growing interest in Chinese medicine
(Financial Times, UK)
 
10 April 2006 Hutchison China Meditech plans London float
(Dow Jones Newswires, UK)
 
10 April 2006 HK Hutchison Whampoa to list Chinese medicine unit on AIM
(Dow Jones Newswires, UK)
 
10 April 2006 Chinese medicine in London float
(Daily Express, UK)
 
10 April 2006 Hong Kong's Hutchsion Whampoa unit to raise 40m stg for AIM listing
(AFX International)